Biofil Chemicals & Pharmaceuticals Ltd

AI
Biofil Chemicals Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Biofil Chemicals & Pharmaceuticals Ltd

₹ 32.5 0.90%
25 Aug 2:08 p.m.
biofilgroup.net BSE: 524396 NSE: BIOFILCHEM
About

Incorporated in 1993, Biofil Chemicals and Pharmaceuticals Ltd deals in Pharmaceuticals and Chemicals products.[1]

Key Points

Business Overview:[1]
BCPL is engaged in diverse pharmaceutical activities including manufacture and trading
of various pharmaceutical and chemical products. It also deals in providing job work facility in respect of manufacturing of pharmaceuticals drug. The company runs its business via 2 units viz. Pharmaceutical Division & Chemicals Division.

Website BSE NSE
  • Market Cap ₹ 52.9 Cr.
  • Current Price ₹ 32.5
  • High / Low ₹ 46.8 / 25.6
  • Stock P/E 110
  • Book Value ₹ 13.2
  • Dividend Yield 0.00 %
  • ROCE 15.8 %
  • ROE 13.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -4.50% over past five years.
  • Company has a low return on equity of 7.20% over last 3 years.
  • Earnings include an other income of Rs.0.31 Cr.
  • Company has high debtors of 355 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
2.43 17.37 5.03 15.20 8.44 2.41 14.20 8.35 6.43 13.54 0.86 7.57 12.35
2.01 17.13 4.84 15.24 8.13 2.29 13.89 8.24 6.42 13.42 0.77 7.14 12.21
Operating Profit 0.42 0.24 0.19 -0.04 0.31 0.12 0.31 0.11 0.01 0.12 0.09 0.43 0.14
OPM % 17.28% 1.38% 3.78% -0.26% 3.67% 4.98% 2.18% 1.32% 0.16% 0.89% 10.47% 5.68% 1.13%
0.02 0.03 0.03 0.41 0.03 0.02 0.02 0.24 2.83 0.06 0.08 0.11 0.06
Interest 0.01 0.01 0.00 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Depreciation 0.11 0.11 0.11 0.08 0.10 0.10 0.10 0.08 0.07 0.07 0.07 0.07 0.07
Profit before tax 0.32 0.15 0.11 0.27 0.23 0.03 0.22 0.26 2.76 0.11 0.10 0.47 0.13
Tax % 25.00% 20.00% 18.18% 11.11% 26.09% 33.33% 27.27% 23.08% 12.68% 27.27% 30.00% 55.32% 23.08%
0.24 0.12 0.09 0.25 0.17 0.02 0.16 0.20 2.41 0.08 0.08 0.21 0.11
EPS in Rs 0.15 0.07 0.06 0.15 0.10 0.01 0.10 0.12 1.48 0.05 0.05 0.13 0.07
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
5.86 13.17 13.45 12.36 23.13 29.69 35.75 22.38 30.04 40.04 33.40 28.40 34.32
5.12 12.30 10.84 11.43 22.11 27.87 34.15 21.05 28.88 39.23 32.55 27.75 33.54
Operating Profit 0.74 0.87 2.61 0.93 1.02 1.82 1.60 1.33 1.16 0.81 0.85 0.65 0.78
OPM % 12.63% 6.61% 19.41% 7.52% 4.41% 6.13% 4.48% 5.94% 3.86% 2.02% 2.54% 2.29% 2.27%
0.46 0.53 0.14 0.10 0.10 0.17 0.80 0.15 0.10 0.49 0.31 3.08 0.31
Interest 0.21 0.15 0.16 0.15 0.16 0.12 0.07 0.04 0.04 0.04 0.04 0.01 0.00
Depreciation 0.25 0.26 0.28 0.30 0.37 0.41 0.41 0.43 0.43 0.40 0.38 0.27 0.28
Profit before tax 0.74 0.99 2.31 0.58 0.59 1.46 1.92 1.01 0.79 0.86 0.74 3.45 0.81
Tax % 20.27% 20.20% 22.51% 20.69% 20.34% 17.81% 34.90% 31.68% 29.11% 17.44% 24.32% 19.42%
0.59 0.78 1.79 0.47 0.48 1.21 1.24 0.70 0.56 0.71 0.56 2.79 0.48
EPS in Rs 0.36 0.48 1.10 0.29 0.29 0.74 0.76 0.43 0.34 0.44 0.34 1.71 0.30
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 8%
5 Years: -5%
3 Years: -2%
TTM: 9%
Compounded Profit Growth
10 Years: 14%
5 Years: 18%
3 Years: 71%
TTM: -83%
Stock Price CAGR
10 Years: 17%
5 Years: -13%
3 Years: -12%
1 Year: -25%
Return on Equity
10 Years: 7%
5 Years: 6%
3 Years: 7%
Last Year: 14%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27 16.27
Reserves -7.86 -5.37 -3.58 -3.11 -2.62 -1.39 -0.14 0.56 1.03 1.93 2.51 5.29
2.98 1.37 1.43 1.56 1.64 1.19 0.43 0.46 0.52 0.44 0.47 3.02
2.36 11.87 7.72 9.44 8.93 26.30 16.68 1.44 13.58 28.44 31.70 18.27
Total Liabilities 13.75 24.14 21.84 24.16 24.22 42.37 33.24 18.73 31.40 47.08 50.95 42.85
9.06 8.98 9.16 9.25 10.29 10.09 9.78 9.42 9.00 8.62 8.34 6.94
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
4.69 15.16 12.68 14.91 13.93 32.28 23.46 9.31 22.40 38.46 42.61 35.91
Total Assets 13.75 24.14 21.84 24.16 24.22 42.37 33.24 18.73 31.40 47.08 50.95 42.85

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.01 0.14 0.71 0.46 1.26 0.89 1.11 -0.22 -0.11 2.39 -1.92 -0.60
-0.17 -0.19 -0.48 -0.38 -1.41 -0.21 -0.10 -0.07 -0.01 -0.02 -0.10 1.14
0.11 0.10 -0.11 -0.02 -0.08 -0.57 -0.83 -0.01 0.02 -0.12 0.00 2.54
Net Cash Flow -0.05 0.05 0.13 0.06 -0.24 0.12 0.18 -0.30 -0.11 2.25 -2.03 3.07
Free Cash Flow -0.16 -0.05 0.23 0.08 -0.15 0.68 1.01 -0.29 -0.12 2.37 -2.02 0.54
CFO/OP 19% 33% 35% 103% 134% 63% 112% 8% 10% 314% -205% 9%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 227.35 387.45 311.00 383.31 189.84 365.25 175.81 116.94 249.08 301.10 418.77 354.59
Inventory Days 15.99 3.46 7.29 38.11 21.73 24.37 48.85 24.20 16.11 24.81 39.52 56.24
Days Payable 198.49 400.98 304.52 341.46 156.66 373.80 178.39 11.25 168.39 268.08 366.66 239.87
Cash Conversion Cycle 44.85 -10.07 13.76 79.95 54.90 15.82 46.27 129.88 96.80 57.83 91.63 170.96
Working Capital Days -47.96 48.50 87.65 104.83 50.81 55.69 64.12 125.25 104.25 69.37 114.09 152.17
ROCE % 8.59% 9.64% 18.72% 5.06% 5.00% 10.08% 12.20% 6.20% 4.73% 4.94% 4.12% 15.79%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Chemicals Segment Revenue
INR Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Permanent Employees
count
Pharma Segment Revenue
INR Lakhs
Vacant Land at Pithampur
sq meters
Related Party Purchases from Cyano Pharma (CPPL)
INR Lakhs
Related Party Sales to Cyano Pharma (CPPL)
INR Lakhs

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

40 Recently
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
46.82% 46.82% 46.82% 46.82% 46.82% 46.82% 46.82% 46.82% 46.79% 46.79% 46.79% 46.79%
0.00% 0.00% 0.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08%
53.10% 53.11% 53.08% 53.11% 53.10% 53.11% 53.11% 53.10% 53.12% 53.13% 53.12% 53.13%
No. of Shareholders 26,12325,86426,58125,48026,42226,11425,91425,68525,19624,82525,35624,999

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports